123 related articles for article (PubMed ID: 34924291)
1. Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone.
Sutton TL; Walker BS; Billingsley KG; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
HPB (Oxford); 2022 Jun; 24(6):986-993. PubMed ID: 34924291
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China.
Chen Q; Li C; Yang H; Zhao H; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):317-323. PubMed ID: 30447909
[TBL] [Abstract][Full Text] [Related]
3. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
Turley RS; Peng PD; Reddy SK; Barbas AS; Geller DA; Marsh JW; Tsung A; Pawlik TM; Clary BM
Cancer; 2012 Jul; 118(14):3571-8. PubMed ID: 22086856
[TBL] [Abstract][Full Text] [Related]
4. Resection Combined with TKI Therapy for Resectable Liver Metastases of Gastrointestinal Stromal Tumours: Results from Three National Centres in China.
Chen Q; Li C; Yang H; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Cai J; Zhou J
J Gastrointest Surg; 2020 Jun; 24(6):1330-1341. PubMed ID: 31187396
[TBL] [Abstract][Full Text] [Related]
5. Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors.
Sutton TL; Walker BS; Billingsley KG; Corless CL; Sheppard BC; Heinrich MC; Mayo SC
Ann Surg Oncol; 2022 Oct; 29(11):7123-7132. PubMed ID: 35829795
[TBL] [Abstract][Full Text] [Related]
6. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
Seesing MF; Tielen R; van Hillegersberg R; van Coevorden F; de Jong KP; Nagtegaal ID; Verhoef C; de Wilt JH;
Eur J Surg Oncol; 2016 Sep; 42(9):1407-13. PubMed ID: 27038995
[TBL] [Abstract][Full Text] [Related]
7. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
Cananzi FC; Belgaumkar A; Lorenzi B; Mudan S
ANZ J Surg; 2014 Dec; 84(12):937-42. PubMed ID: 25444423
[TBL] [Abstract][Full Text] [Related]
8. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
Cananzi FC; Belgaumkar AP; Lorenzi B; Mudan S
ANZ J Surg; 2014 Dec; 84(12):E1-8. PubMed ID: 23647808
[TBL] [Abstract][Full Text] [Related]
9. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis.
Sutton TL; Wong LH; Walker BS; Dewey EN; Eil R; Lopez CD; Kardosh A; Chen EY; Rocha FG; Billingsley KG; Mayo SC
Surgery; 2023 Jun; 173(6):1314-1321. PubMed ID: 36435651
[TBL] [Abstract][Full Text] [Related]
10. Management of liver metastases of gastrointestinal stromal tumors (GIST).
Vassos N; Agaimy A; Hohenberger W; Croner RS
Ann Hepatol; 2015; 14(4):531-9. PubMed ID: 26019040
[TBL] [Abstract][Full Text] [Related]
11. A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors.
Hakimé A; Le Cesne A; Deschamps F; Farouil G; Boudabous S; Aupérin A; Domont J; Debaere T
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):132-9. PubMed ID: 23589213
[TBL] [Abstract][Full Text] [Related]
12. Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors.
Zaydfudim V; Okuno SH; Que FG; Nagorney DM; Donohue JH
J Surg Res; 2012 Oct; 177(2):248-54. PubMed ID: 22831567
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant tyrosine kinase inhibitor therapy for patients with gastrointestinal stromal tumor: A propensity-matched analysis.
Wong LH; Sutton TL; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
Am J Surg; 2022 Jul; 224(1 Pt B):624-628. PubMed ID: 35382931
[TBL] [Abstract][Full Text] [Related]
14. Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor.
Sutton TL; Walker BS; Billingsley KG; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
Ann Surg Oncol; 2021 Nov; 28(12):7912-7920. PubMed ID: 33969462
[TBL] [Abstract][Full Text] [Related]
15. Thermal ablation versus hepatic resection for the treatment of liver metastases from gastrointestinal stromal tumors: a retrospective study.
Yang DP; Zhuang BW; Wang YZ; Lin MX; Xu M; Kuang M; Lei YY; Xie XY; Xie XH
Int J Hyperthermia; 2020; 37(1):592-599. PubMed ID: 32484012
[No Abstract] [Full Text] [Related]
16. Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).
Ye YJ; Gao ZD; Poston GJ; Wang S
Eur J Surg Oncol; 2009 Aug; 35(8):787-92. PubMed ID: 19185444
[TBL] [Abstract][Full Text] [Related]
17. Has the survival rate for surgically resected gastric gastrointestinal stromal tumors improved in the tyrosine kinase inhibitor era?
Pedroso FE; Raut CP; Xiao H; Yeo CJ; Koniaris LG
Ann Surg Oncol; 2012 Jun; 19(6):1748-58. PubMed ID: 22290567
[TBL] [Abstract][Full Text] [Related]
18. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.
Roland CL; Bednarski BK; Watson K; Torres KE; Cormier JN; Wang WL; Lazar AJ; Somaiah N; Hunt KK; Feig BW
J Surg Oncol; 2018 Apr; 117(5):879-885. PubMed ID: 29448300
[TBL] [Abstract][Full Text] [Related]
19. Surgical Management of Metastatic Gastrointestinal Stromal Tumors.
Yonkus JA; Alva-Ruiz R; Grotz TE
Curr Treat Options Oncol; 2021 Mar; 22(5):37. PubMed ID: 33743084
[TBL] [Abstract][Full Text] [Related]
20. Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role?
Sutton TL; Walker BS; Billingsley KG; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
Surgery; 2021 Nov; 170(5):1481-1486. PubMed ID: 34090672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
